Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06328621 · ClinicalTrials.gov registry record
Lung Cancer Risk Assessment and Etiology
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 109
- Enrollment target
NCT06328621 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 109 participants.
The verdict
NCT06328621 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
This study examines the biological and social determinants that may increase the risk for lung cancer in patients and never-smoking individuals. Biological characteristics of a person can include their genetics and social determinants of a person can include their education, income, and environment, all of which can impact their health. Information collected in this study may help increase early detection of lung cancer.
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Computed Tomography
- OTHER Survey Administration
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2026-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06328621
The ClinicalTrials.gov registry entry for NCT06328621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT06328621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06328621 about?
NCT06328621 is a clinical study titled "Lung Cancer Risk Assessment and Etiology". This study examines the biological and social determinants that may increase the risk for lung cancer in patients and never-smoking individuals. Biological characteristics of a person can include their genetics and social determinants of a person can include their education, income, and environment,...
What is the current status of trial NCT06328621?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2021-07-02. Estimated completion is 2026-03-13.
What interventions are being tested in trial NCT06328621?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Computed Tomography (PROCEDURE), Survey Administration (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT06328621?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.